Correlation Between Comera Life and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Comera Life and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Comera Life and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Comera Life Sciences and AN2 Therapeutics, you can compare the effects of market volatilities on Comera Life and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Comera Life with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Comera Life and AN2 Therapeutics.
Diversification Opportunities for Comera Life and AN2 Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Comera and AN2 is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Comera Life Sciences and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Comera Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Comera Life Sciences are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Comera Life i.e., Comera Life and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Comera Life and AN2 Therapeutics
If you would invest 204.00 in AN2 Therapeutics on September 2, 2024 and sell it today you would lose (37.00) from holding AN2 Therapeutics or give up 18.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.79% |
| Values | Daily Returns |
Comera Life Sciences vs. AN2 Therapeutics
Performance |
| Timeline |
| Comera Life Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| AN2 Therapeutics |
Comera Life and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Comera Life and AN2 Therapeutics
The main advantage of trading using opposite Comera Life and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Comera Life position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Comera Life vs. SAB Biotherapeutics | Comera Life vs. Processa Pharmaceuticals | Comera Life vs. Third Harmonic Bio | Comera Life vs. Indaptus Therapeutics |
| AN2 Therapeutics vs. Tff Pharmaceuticals | AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Inhibrx | AN2 Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |